Young is an Operating Partner of LSV. He assists the LSV biopharmaceutical team with deal sourcing, due diligence, and portfolio company management. He has served in this role since April 2021.
Young is an accomplished executive with significant operating and venture capital experience.
He has held a variety of leadership roles over ten years as a C-suite executive at Momenta Pharmaceuticals, a public biotech company, prior to its sale to Johnson & Johnson for $6.5 billion.
Young was most recently Chief Financial and Business Officer at Momenta, where he had responsibility for business development, strategy, finance, investor relations, and commercial. Young has led public equity financings raising nearly $500 million and also led the company’s sale to J&J. Prior to Momenta, Young was a business development professional at Biogen, driving a variety of transactions. Young previously worked at ATV, working with the team on investments including Acceleron, Five Prime, Hypnion, and Zeltiq.